ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine +40 more
wiley +1 more source
Data driven selection of consensus docking pipelines for structure based hit identification. [PDF]
Agha H +6 more
europepmc +1 more source
Elite-Guided Nutcracker Optimization Algorithm with Memory-Differential Spiral Search for Feature Selection. [PDF]
Pang B, Kang C.
europepmc +1 more source
Effectiveness and safety of atorvastatin/ ezetimibe fixed-dose combination in hypercholesterolemia: a systematic review and network meta-analysis. [PDF]
Qian J, Zhang X, Li Q, Chen S.
europepmc +1 more source
Oxygenation and Spatial Heterogeneity Shape Radiotherapy Protocol Ranking Through Phenotypic Adaptation. [PDF]
Albanese F, Chiari G, Delitala ME.
europepmc +1 more source
Efficacy and safety of first-line immunotherapy-related induction and maintenance therapy for extensive-stage small cell lung cancer: a systematic review and Bayesian network meta-analysis. [PDF]
Yu HJ, Liu JC, Zhang DS, Chen Z, Deng Q.
europepmc +1 more source
Selected traditional Chinese medicines for treating amyotrophic lateral sclerosis: a Bayesian network meta-analysis based on randomised controlled trials. [PDF]
Shen C +9 more
europepmc +1 more source

